ABT has come back into longterm daily uptrend. on the hourly chart this may be a double bottom and zooming out on the daily we are pretty close to the .618 retracement. Seeing slgiht rejection on the hourly so this may be good for a quick scalp
Upside target in the $100 region , earnings approaching in October could be the stimulus for that move.
ABT specialize in Diabetes, which is one of the fastest growing disease in the world, the potential growth for ABT in huge which is reflected in the increased hiring in its European bases.
As more of the world comes out of poverty, a unfortunate result is the...
Investing position: In Rising section of high profit & low risk so far. But it would be in falling section tomorrow
S&D strength Trend: In the midst of an adjustment trend of downward direction box pattern price flow marked by limited rises and downward fluctuations.
Today's S&D strength Flow: Supply-Demand(S&D) strength flow appropriate to the current...
Abbotts quite simply does not miss earnings, a fantastic company and fantastic product in the ever increasing market of Diabetes treatment. Despite this we see a little stagnant price action lately and a pullback is quite possible.